Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
How food assistance programs can feed families and nourish their dignity - 2Instructions to Warmly greet Discretion and Thoughtfulness
- 3Extraordinary Snowboarding Objections All over the Planet
- 4How a cocktail of rogue storms and climate chaos unleashed deadly flooding across Asia
- 5Viable Monetary Tips to Advance Your Monetary Circumstance
- Dominating Monetary Administration: A Bit by bit Manual for Making an Individual Financial plan
- Figure out How to Reveal Stowed away Open Record Rewards
- 7 Well known Vacation spots In The US
- Instructions to Perform Fundamental Upkeep on Your Slam 1500.
- A definitive Frozen yogurt Standoff: Which Flavor Rules?
- Finding the Force of Mentorship: Self-awareness Through Direction
- Instructions to Arrange Your Compensation During Medical caretaker Prospective employee meetings
- Putting resources into Yourself: Self-awareness Techniques
- Hamas propaganda expert explains Israel's internal conflicts influenced Hamas's Oct. 7 assault
